• CARIPRAZINE CHEMBL2028019 FDA Approved

    Alternate Names:

    Cariprazine
    RGH-188
    223366006
    7671
    Vraylar
    839712-12-8
    trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N’,N’-dimethylurea hydrochloride
    DB06016
    UREA, N'-(TRANS-4-(2-(4-(2,3-DICHLOROPHENYL)-1-PIPERAZINYL)ETHYL)CYCLOHEXYL)-N,N-DIMETHYL-
    TRANS-1-{4-[2-[4-(2,3-DICHLOROPHENYL)-PIPERAZIN-1-YL]-ETHYL]-CYCLOHEXYL}-3,3-DIMETHYL-UREA
    955400-75-6
    N'-[TRANS-4-[2-[4-(2,3-DICHLOROPHENYL)-1-PIPERAZINYL]ETHYL]CYCLOHEXYL]-N,N-DIMETHYLUREA
    3-[4-[2-[4-(2,3-DICHLOROPHENYL)PIPERAZIN-1-YL]ETHYL]CYCLOHEXYL]-1,1-DIMETHYLUREA
    D09997
    FT-0664381
    HY-14763
    HE395618
    BC600740
    CS-1569
    ZINC100153731
    BDBM50443101
    BDBM50443094
    BDBM50382290
    3526AH
    KPWSJANDNDDRMB-QAQDUYKDSA-N
    SCHEMBL7861573
    RGH188
    GTPL7671
    F6RJL8B278
    SCHEMBL184343
    SCHEMBL184342
    C21H32CL2N4O
    CARIPRAZINE [USAN:INN]
    CARIPRAZINE (USAN/INN)
    VRAYLARREG
    CHEMBL3085826
    UNII-F6RJL8B278
    RGH 188
    11154555

    Drug Info:

    Drug Categories psycholeptics
    Drug Categories nervous system
    Drug Categories heterocyclic compounds, 1-ring
    Drug Categories heterocyclic compounds
    Drug Categories cytochrome p-450 cyp3a4 substrates
    Drug Categories cytochrome p-450 cyp2d6 substrates
    Drug Categories antipsychotic agents (second generation [atypical])
    Drug Categories antipsychotic agents
    Drug Groups approved
    Drug Type small molecule
    FDA Approval not approved
    Drug Class Small molecule
    Drug Indications antipsychotic agent
    (0 More Sources)